These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6947115)

  • 41. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
    Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D; Cameron AE
    Int J Tissue React; 1984; 6(3):205-11. PubMed ID: 6480267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
    Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
    Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide.
    Grdina DJ; Hunter N; Kataoka Y; Murley JS; Milas L
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):22-7. PubMed ID: 10348256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of combination treatment with cyclophosphamide and nonspecific passive immunization on a transplantable tumor in WKA rats.
    Gotohda E; Kawamura T; Sendo F; Nakayama M; Akiyama J
    Cancer Res; 1976 Jul; 36(7 PT 1):2119-23. PubMed ID: 1277122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Host-mediated inhibition of rat bladder cancer growth by cyclophosphamide and purine salvage pathway-related enzyme activity of lymphocytes.
    Iwaguchi T; Nakamura M; Kitagawa H
    Jpn J Exp Med; 1984 Oct; 54(5):201-6. PubMed ID: 6442929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells.
    Wang Y; O'Rourke J; Cone RE
    Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.
    Reznikoff CA; Bertram JS; Brankow DW; Heidelberger C
    Cancer Res; 1973 Dec; 33(12):3239-49. PubMed ID: 4796800
    [No Abstract]   [Full Text] [Related]  

  • 50. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
    Artym J; Zimecki M; Kruzel ML
    Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profile of cytokines produced in tumor tissue after administration of cyclophosphamide in a combination therapy with tumor necrosis factor.
    Takiguchi K; Nakamoto T; Inagawa H; Kohchi C; Nishizawa T; Nagasue N; Soma G
    Anticancer Res; 2004; 24(3a):1823-8. PubMed ID: 15274362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for splenic suppressor cells in C3H/He, T-cell-deprived C3H/He, and nude mice bearing a 3-methylcholanthrene-induced fibrosarcoma.
    Poupon MF; Kolb JP; Lespinats G
    J Natl Cancer Inst; 1976 Dec; 57(6):1241-7. PubMed ID: 1087353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerance induction to multiple minor histoincompatible cells by activated B cells is associated with preferential activation of Th2 cells.
    Gorczynski RM; Kiziroglu F
    Transplantation; 1994 Jul; 58(1):51-8. PubMed ID: 8036708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of cyclophosphamide on syngeneic transplantation of adenovirus 12-transformed tumor cells in C3H/he mice.
    Pauluzzi S; Merletti L
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):310-5. PubMed ID: 20903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
    Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice.
    Ben-Hur H; Ben-Meir A; Hagay Z; Ben-Meir A; Berman V; Schwartsburd B; Gurevich P; Sandler B; Tendler Y; Zinder O; Zusman I
    Anticancer Res; 1998; 18(6A):4237-41. PubMed ID: 9891473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.